Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption. (Q54590201)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

anti-retroviral agent

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

Maria Cecilia Sucupira

object named as

Maria Cecilia A Sucupira

5

0 references

6

object named as

Ester C Sabino

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

author name string

Wilson Pereira Silva

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

Domingos E M Santos

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

Adriana Brunstein

4

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

Ricardo Sobhie Diaz

7

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

language of work or name

0 references

publication date

25 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

354

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

35-47

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Evidence for Selection of more Adapted Human Immunodeficiency Virus Type 1 Recombinant Strains in a Dually Infected Transfusion Recipient

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Lack of dual HIV infection in a transfusion recipient exposed to two seropositive blood components

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Divergence of HIV-1 quasispecies in an epidemiologic cluster

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

HIV type 1 tat gene heteroduplex mobility assay as a tool to establish epidemiologic relationships among HIV type 1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Relation between Changes in Cellular Load, Evolution of Viral Phenotype, and the Clonal Composition of Virus Populations in the Course of Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Gender differences in HIV-1 diversity at time of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Fitness of human immunodeficiency virus type 1 protease inhibitor-selected single mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

V3 Region Polymorphisms in HIV-1 from Brazil: Prevalence of Subtype B Strains Divergent from North American/European Prototype and Detection of Subtype F

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

MODELTEST: testing the model of DNA substitution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.039

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2006.04.039

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16872654

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54590201&oldid=1964077576"